Physician

Vinod Mandadi Nair, M.D.

According to 2025 Medicare claims, Vinod Nair, M.D. (NPI: 1770550857) practices interventional cardiology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Terrebonne, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (NPI: 1982689113; TIN: 720993441) and primary practice location at 70360-4413. Nair is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Nair's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 775 traditional Medicare patients, billed 8,296 HCPCS/CPT codes, and received $480,685 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,829 prescription claims across 1,436 beneficiaries totaling $1,661,394 in drug costs, led by Eliquis (Apixaban). DME data shows 111 claims. Open Payments data shows 30 records totaling $1,026. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $538,332 to $480,685. In contrast, Part D prescription costs have moved sharply higher in recent years, from $350,325 to $1,661,394. For DME billing, this smaller-volume category fell sharply in recent years, from $9,423 to $15,154.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,767	29,992	$538,332
2016	1,952	34,705	$964,166
2017	1,854	28,465	$1,108,030
2018	1,777	27,734	$1,140,160
2019	1,291	16,801	$815,288
2020	1,080	10,285	$740,561
2021	979	8,507	$700,838
2022	872	8,298	$684,173
2023	886	7,898	$631,852
2024	775	8,296	$480,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	658	7,740	$350,325
2016	725	9,024	$433,732
2017	827	9,969	$523,517
2018	960	10,167	$608,793
2019	1,033	10,691	$690,548
2020	1,045	10,976	$812,716
2021	1,196	12,305	$1,065,168
2022	1,280	14,300	$1,359,233
2023	1,333	15,011	$1,572,321
2024	1,436	15,829	$1,661,394

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	36	$3,314
2016	N/R	121	$30,718
2017	N/R	90	$28,522
2018	85	258	$6,330
2019	107	286	$43,296
2020	99	378	$42,451
2021	39	150	$6,369
2022	64	165	$4,475
2023	N/R	85	$2,853
2024	36	111	$2,133

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	543	960	$79
80061	Blood test, lipids (cholesterol and triglycerides)	407	539	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	550	1,019	$11
84460	Liver enzyme (sgpt), level	402	541	$5
84450	Liver enzyme (sgot), level	402	541	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	673	31,271	$608,049
Entresto	Sacubitril/Valsartan	230	10,940	$241,875
Xarelto	Rivaroxaban	217	11,130	$207,597
Jardiance	Empagliflozin	138	6,249	$121,769
Repatha Sureclick	Evolocumab	95	3,729	$73,870

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	22	$1,137
A7038	Filter, disposable, used with positive airway pressure device	N	13	29	$286
A7037	Tubing used with positive airway pressure device	N	12	28	$282
A7035	Headgear used with positive airway pressure device	N	11	18	$275
A7046	Water chamber for humidifier, used with positive airway pressure device, replacement, each	N	N/R	14	$153

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$1,026	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vinod Mandadi Nair, M.D.?

Tedicare shows public-source Medicare data for Vinod Mandadi Nair, M.D. (NPI 1770550857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinod Mandadi Nair, M.D. have ACO affiliation data?

Vinod Mandadi Nair, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535).

What billing organization is linked to Vinod Mandadi Nair, M.D.?

Vinod Mandadi Nair, M.D. is linked to CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (billing NPI 1982689113) in the available physician profile data.

Does Vinod Mandadi Nair, M.D. have Open Payments data?

Vinod Mandadi Nair, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.